Monobenzone 40% Topical Treatment for Extensive Vitiligo – Professional Use Formula

Monobenzone 40% Topical Treatment is a high-strength depigmenting formulation designed for professional use in patients with extensive vitiligo. This advanced formula contains Monobenzone 40% w/w (Monobenzyl Ether of Hydroquinone) to support complete and permanent depigmentation of remaining pigmented skin, helping achieve a uniform skin tone.

---

Product Overview

• ✔ High-potency Monobenzone 40% formula

• ✔ Intended for extensive or generalized vitiligo

• ✔ Professional-use strength

• ✔ Supports permanent depigmentation therapy

• ✔ Topical cream for controlled application

---

How Monobenzone 40% Works

Monobenzone works by permanently destroying melanocytes (pigment-producing cells) in treated areas. This process gradually removes remaining pigmentation, allowing untreated darker areas to match already depigmented skin.

• Results develop progressively over several months

• Depigmentation is irreversible

• Not a repigmentation treatment

---

Indications

Recommended for:

• Patients with vitiligo affecting more than 50% of body surface area

• Individuals seeking complete depigmentation for uniform skin tone

• Cases managed under dermatologist supervision

Not intended for:

• Cosmetic skin bleaching

• Melasma or freckles

• Minor or localized pigmentation concerns

---

Directions for Professional Use

• Apply a thin layer to pigmented areas once or twice daily, or as directed by a healthcare professional

• Wash hands after application

• Use broad-spectrum sunscreen daily

• Avoid unnecessary sun exposure

Treatment response may begin within 1–2 months, with significant depigmentation developing over 6–12 months depending on skin response.

---

Safety Information

Monobenzone 40% is a high-strength depigmenting agent and must be used under medical supervision.

Possible side effects include:

• Skin irritation or redness

• Burning or dryness

• Uneven depigmentation

• Increased sensitivity to sunlight

Permanent pigment loss can extend beyond treated areas.

---

Important Notice

Monobenzone 40% Topical Treatment is intended strictly for medical depigmentation therapy in extensive vitiligo. Because results are permanent, patients should carefully discuss risks and expectations with a qualified dermatologist before starting treatment.